USPTO serial 79066673
ALIENOR FARMA
Reviewed by CopyMark Law Group
Reg. 3767622Status 404
- Filing date
- Status date
- Registration date
- Mar 30, 2010
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALIENOR FARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Bleaching preparations and other substances for laundry use, namely, laundry detergent and laundry starch; cleaning, polishing, scouring and abrasive preparations; soaps, perfumes, essential oils, cosmetics, hair lotions; dentifrices; depilatories; make-up removing preparations; lipsticks; beauty masks; shaving products, namely, shaving cream and shaving foam | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for skin care; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical and veterinary preparations, namely, diagnostic preparations for medical and veterinary use and diagnostic preparations for medical or veterinary purposes; sanitary preparations for medical use; dietetic foods adapted for medical use; Dietetic sugar for medical use; baby food; medical plasters; materials for dressings, namely, bandages and gauze; material for stopping teeth; dental wax; all purpose disinfectants; disinfectants for sanitary and hygienic purposes; medicated bath preparations; sanitary pads; chemical preparations for sanitary purposes; chemical preparations in the nature of reagents for medical or veterinary purposes; medicinal herbs; herbal teas for medicinal purposes; antiparasitic preparations; sugar replacement for medicinal purposes | SECTION 71 - CANCELLED | — |
| 042 | Medical research provided by pharmaceutical laboratories; scientific research provided by pharmaceutical laboratories; medical and scientific research provided by pharmaceutical laboratories, namely, conducting clinical trials; research and development of new products for third parties; scientific research, analysis and development services provided in the fields of chemistry, biology, biotechnology, pharmacology, cosmetology, and bacteriology; scientific research services provided by medical analysis laboratories | SECTION 71 - CANCELLED | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings and animals; medical assistance services; pharmaceutical advice; providing medical advice and consultancy services in the field of clinical pharmacology; consultancy services in the field of health; medical consultation | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ALIENOR FARMA
- Other trademarks owned by ALIENOR FARMA
- Other trademarks owned by ALIENOR FARMA
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALIENOR FARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 22, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Mar 22, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 4, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 10, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 10, 2017 | INPC | INVALIDATION PROCESSED | — |
| Jul 4, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 4, 2016 | C71T | CANCELLED SECTION 71 | — |
| May 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 19, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 19, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 30, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 30, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 12, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 7, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 4, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Dec 1, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 1, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2009 | ALIE | ASSIGNED TO LIE | — |
| Oct 20, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 8, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 20, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 20, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 18, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 17, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 10, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |